United States
US 12,702,711 B2
Pharmaceutical products and stable liquid compositions of IL-17 antibodies
US 12,702,711 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-11. Applicant: NOVARTIS AG. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- NOVARTIS AG
- Inventors
- Susanne JOERG; Kathrin SERNO-SCHERSCH
- Publication date
- 2026-08-11
- Filing date
- 2025-10-31
- Document type
- B2 Granted patent
- Also written as
- US 12,702,711 B2 · US12702711 · 12702711
Abstract
The disclosure is directed to pharmaceutical products and stable liquid compositions of IL-17 antibodies and antigen-binding fragments thereof, e.g., AIN457 (secukinumab), and processes of making these pharmaceutical products and compositions. The disclosure is also directed to the use of these pharmaceutical products and liquid compositions (e.g., as part of a kit having instructions for use) for the treatment of various IL-17-mediated disorders (e.g., autoimmune disorders, such as psoriasis, ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis).
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free